nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A4—chronic kidney failure	0.385	0.546	CbGaD
Nefazodone—ABCB1—chronic kidney failure	0.321	0.454	CbGaD
Nefazodone—SLC6A2—sympathetic nervous system—chronic kidney failure	0.00756	0.0894	CbGeAlD
Nefazodone—HTR2A—arteriole—chronic kidney failure	0.00713	0.0843	CbGeAlD
Nefazodone—HTR2A—sympathetic nervous system—chronic kidney failure	0.00454	0.0537	CbGeAlD
Nefazodone—HTR2A—vein—chronic kidney failure	0.00425	0.0503	CbGeAlD
Nefazodone—SLC6A3—nerve—chronic kidney failure	0.00354	0.0419	CbGeAlD
Nefazodone—SLC6A2—nerve—chronic kidney failure	0.00286	0.0338	CbGeAlD
Nefazodone—HTR2A—urine—chronic kidney failure	0.00249	0.0294	CbGeAlD
Nefazodone—SLC6A4—blood plasma—chronic kidney failure	0.00246	0.029	CbGeAlD
Nefazodone—CYP3A4—urine—chronic kidney failure	0.00231	0.0272	CbGeAlD
Nefazodone—CYP2D6—urine—chronic kidney failure	0.00227	0.0268	CbGeAlD
Nefazodone—HTR1A—blood plasma—chronic kidney failure	0.00218	0.0258	CbGeAlD
Nefazodone—CYP3A7-CYP3A51P—nephron tubule—chronic kidney failure	0.002	0.0236	CbGeAlD
Nefazodone—HTR2A—artery—chronic kidney failure	0.00173	0.0205	CbGeAlD
Nefazodone—HTR2A—nerve—chronic kidney failure	0.00172	0.0203	CbGeAlD
Nefazodone—CYP3A7-CYP3A51P—cortex of kidney—chronic kidney failure	0.00171	0.0202	CbGeAlD
Nefazodone—ADRA1B—renal system—chronic kidney failure	0.00168	0.0198	CbGeAlD
Nefazodone—ADRA1B—kidney—chronic kidney failure	0.00162	0.0192	CbGeAlD
Nefazodone—CYP3A5—blood plasma—chronic kidney failure	0.0016	0.0189	CbGeAlD
Nefazodone—ADRA2A—blood plasma—chronic kidney failure	0.00153	0.0181	CbGeAlD
Nefazodone—HTR2A—blood plasma—chronic kidney failure	0.0013	0.0154	CbGeAlD
Nefazodone—CYP3A4—blood plasma—chronic kidney failure	0.0012	0.0142	CbGeAlD
Nefazodone—CYP2D6—blood plasma—chronic kidney failure	0.00118	0.014	CbGeAlD
Nefazodone—Acetophenazine—DRD1—chronic kidney failure	0.00108	0.111	CrCbGaD
Nefazodone—HTR1A—renal system—chronic kidney failure	0.00102	0.0121	CbGeAlD
Nefazodone—HTR1A—cardiovascular system—chronic kidney failure	0.00101	0.0119	CbGeAlD
Nefazodone—SLC6A4—digestive system—chronic kidney failure	0.000944	0.0112	CbGeAlD
Nefazodone—ADRA1A—renal system—chronic kidney failure	0.000942	0.0111	CbGeAlD
Nefazodone—ADRA1A—cardiovascular system—chronic kidney failure	0.000931	0.011	CbGeAlD
Nefazodone—Domperidone—CYP2B6—chronic kidney failure	0.000913	0.0939	CrCbGaD
Nefazodone—SLC6A2—gonad—chronic kidney failure	0.000909	0.0107	CbGeAlD
Nefazodone—SLC6A4—blood—chronic kidney failure	0.0009	0.0106	CbGeAlD
Nefazodone—ABCB1—blood plasma—chronic kidney failure	0.000852	0.0101	CbGeAlD
Nefazodone—CYP3A5—nephron tubule—chronic kidney failure	0.000827	0.00977	CbGeAlD
Nefazodone—CYP3A5—renal system—chronic kidney failure	0.000752	0.00888	CbGeAlD
Nefazodone—ADRA1A—blood—chronic kidney failure	0.000736	0.0087	CbGeAlD
Nefazodone—CYP3A5—kidney—chronic kidney failure	0.000727	0.00859	CbGeAlD
Nefazodone—CYP3A5—cortex of kidney—chronic kidney failure	0.000708	0.00836	CbGeAlD
Nefazodone—ADRA2A—urethra—chronic kidney failure	0.000704	0.00832	CbGeAlD
Nefazodone—Zuclopenthixol—DRD1—chronic kidney failure	0.000685	0.0705	CrCbGaD
Nefazodone—ADRA2A—cortex of kidney—chronic kidney failure	0.000675	0.00797	CbGeAlD
Nefazodone—ADRA2A—gonad—chronic kidney failure	0.000643	0.00759	CbGeAlD
Nefazodone—Aripiprazole—DRD1—chronic kidney failure	0.000634	0.0651	CrCbGaD
Nefazodone—CYP3A5—digestive system—chronic kidney failure	0.000616	0.00729	CbGeAlD
Nefazodone—HTR2A—renal system—chronic kidney failure	0.000609	0.0072	CbGeAlD
Nefazodone—Perphenazine—CYP2C18—chronic kidney failure	0.000605	0.0622	CrCbGaD
Nefazodone—HTR2A—cardiovascular system—chronic kidney failure	0.000602	0.00711	CbGeAlD
Nefazodone—Thioproperazine—DRD1—chronic kidney failure	0.000601	0.0618	CrCbGaD
Nefazodone—HTR2A—kidney—chronic kidney failure	0.000589	0.00696	CbGeAlD
Nefazodone—CYP3A5—blood—chronic kidney failure	0.000587	0.00694	CbGeAlD
Nefazodone—CYP3A4—renal system—chronic kidney failure	0.000564	0.00667	CbGeAlD
Nefazodone—ADRA2A—blood—chronic kidney failure	0.00056	0.00662	CbGeAlD
Nefazodone—CYP2D6—renal system—chronic kidney failure	0.000555	0.00656	CbGeAlD
Nefazodone—HTR2A—gonad—chronic kidney failure	0.000546	0.00646	CbGeAlD
Nefazodone—CYP3A4—kidney—chronic kidney failure	0.000545	0.00644	CbGeAlD
Nefazodone—CYP2D6—kidney—chronic kidney failure	0.000537	0.00634	CbGeAlD
Nefazodone—Fluphenazine—DRD1—chronic kidney failure	0.000511	0.0525	CrCbGaD
Nefazodone—HTR2A—digestive system—chronic kidney failure	0.0005	0.00591	CbGeAlD
Nefazodone—HTR2A—blood—chronic kidney failure	0.000476	0.00563	CbGeAlD
Nefazodone—CYP3A4—digestive system—chronic kidney failure	0.000463	0.00547	CbGeAlD
Nefazodone—CYP2D6—digestive system—chronic kidney failure	0.000455	0.00538	CbGeAlD
Nefazodone—Perphenazine—CYP2B6—chronic kidney failure	0.000449	0.0462	CrCbGaD
Nefazodone—CYP3A4—blood—chronic kidney failure	0.000441	0.00521	CbGeAlD
Nefazodone—ABCB1—nephron tubule—chronic kidney failure	0.000439	0.00519	CbGeAlD
Nefazodone—CYP2D6—blood—chronic kidney failure	0.000434	0.00513	CbGeAlD
Nefazodone—Perphenazine—DRD1—chronic kidney failure	0.000404	0.0415	CrCbGaD
Nefazodone—ABCB1—renal system—chronic kidney failure	0.000399	0.00472	CbGeAlD
Nefazodone—Quetiapine—DRD1—chronic kidney failure	0.000396	0.0407	CrCbGaD
Nefazodone—ABCB1—cardiovascular system—chronic kidney failure	0.000395	0.00466	CbGeAlD
Nefazodone—ABCB1—urethra—chronic kidney failure	0.000392	0.00463	CbGeAlD
Nefazodone—ABCB1—kidney—chronic kidney failure	0.000386	0.00456	CbGeAlD
Nefazodone—ABCB1—cortex of kidney—chronic kidney failure	0.000376	0.00444	CbGeAlD
Nefazodone—ABCB1—gonad—chronic kidney failure	0.000358	0.00423	CbGeAlD
Nefazodone—Domperidone—CYP3A4—chronic kidney failure	0.000351	0.0361	CrCbGaD
Nefazodone—ABCB1—digestive system—chronic kidney failure	0.000327	0.00387	CbGeAlD
Nefazodone—ABCB1—blood—chronic kidney failure	0.000312	0.00369	CbGeAlD
Nefazodone—Domperidone—ABCB1—chronic kidney failure	0.000292	0.03	CrCbGaD
Nefazodone—Perphenazine—CYP2C19—chronic kidney failure	0.000271	0.0279	CrCbGaD
Nefazodone—Aripiprazole—CYP3A4—chronic kidney failure	0.000271	0.0278	CrCbGaD
Nefazodone—Trazodone—CYP3A4—chronic kidney failure	0.000269	0.0277	CrCbGaD
Nefazodone—Quetiapine—CYP2C19—chronic kidney failure	0.000266	0.0274	CrCbGaD
Nefazodone—Prochlorperazine—CYP3A4—chronic kidney failure	0.000241	0.0248	CrCbGaD
Nefazodone—Aripiprazole—ABCB1—chronic kidney failure	0.000225	0.0232	CrCbGaD
Nefazodone—Trazodone—ABCB1—chronic kidney failure	0.000224	0.0231	CrCbGaD
Nefazodone—Thioproperazine—ALB—chronic kidney failure	0.000224	0.023	CrCbGaD
Nefazodone—Fluphenazine—ABCB1—chronic kidney failure	0.000182	0.0187	CrCbGaD
Nefazodone—Perphenazine—CYP3A4—chronic kidney failure	0.000173	0.0177	CrCbGaD
Nefazodone—Quetiapine—CYP3A4—chronic kidney failure	0.000169	0.0174	CrCbGaD
Nefazodone—Trifluoperazine—ABCB1—chronic kidney failure	0.000145	0.0149	CrCbGaD
Nefazodone—Quetiapine—ABCB1—chronic kidney failure	0.000141	0.0145	CrCbGaD
Nefazodone—HTR2A—GPCR downstream signaling—POMC—chronic kidney failure	2.01e-05	0.0001	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—F2—chronic kidney failure	2e-05	0.0001	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—F2—chronic kidney failure	2e-05	9.99e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—DRD1—chronic kidney failure	2e-05	9.99e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—CYP1A1—chronic kidney failure	1.99e-05	9.95e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—CCL2—chronic kidney failure	1.96e-05	9.82e-05	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—POMC—chronic kidney failure	1.96e-05	9.82e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—F2—chronic kidney failure	1.96e-05	9.78e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CYBA—chronic kidney failure	1.93e-05	9.67e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CYP3A4—chronic kidney failure	1.93e-05	9.65e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ABCA1—chronic kidney failure	1.9e-05	9.49e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CPT1A—chronic kidney failure	1.89e-05	9.45e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCG1—chronic kidney failure	1.88e-05	9.42e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—AVP—chronic kidney failure	1.87e-05	9.37e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HBEGF—chronic kidney failure	1.87e-05	9.33e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—AVP—chronic kidney failure	1.86e-05	9.32e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—MTHFR—chronic kidney failure	1.86e-05	9.27e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	1.84e-05	9.22e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—LIPC—chronic kidney failure	1.84e-05	9.21e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CYP2C19—chronic kidney failure	1.84e-05	9.21e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HBEGF—chronic kidney failure	1.83e-05	9.14e-05	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—POMC—chronic kidney failure	1.82e-05	9.12e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—POMC—chronic kidney failure	1.82e-05	9.1e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PPARA—chronic kidney failure	1.82e-05	9.1e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—F2—chronic kidney failure	1.82e-05	9.09e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—VEGFA—chronic kidney failure	1.81e-05	9.07e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ARG2—chronic kidney failure	1.81e-05	9.03e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—AVP—chronic kidney failure	1.78e-05	8.92e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—POMC—chronic kidney failure	1.78e-05	8.91e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—EDN1—chronic kidney failure	1.78e-05	8.91e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—CCL2—chronic kidney failure	1.78e-05	8.91e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CPT1A—chronic kidney failure	1.78e-05	8.9e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—EDN1—chronic kidney failure	1.77e-05	8.86e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LCAT—chronic kidney failure	1.77e-05	8.86e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL5—chronic kidney failure	1.77e-05	8.84e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL5—chronic kidney failure	1.76e-05	8.79e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CAT—chronic kidney failure	1.75e-05	8.77e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—CCL2—chronic kidney failure	1.74e-05	8.72e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—LIPC—chronic kidney failure	1.74e-05	8.68e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	1.74e-05	8.68e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—LPL—chronic kidney failure	1.73e-05	8.64e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—LPL—chronic kidney failure	1.72e-05	8.6e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ABCB1—chronic kidney failure	1.71e-05	8.53e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—SCARB1—chronic kidney failure	1.7e-05	8.51e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HBEGF—chronic kidney failure	1.7e-05	8.49e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—EDN1—chronic kidney failure	1.7e-05	8.48e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS1—chronic kidney failure	1.68e-05	8.42e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL5—chronic kidney failure	1.68e-05	8.42e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—TGFB1—chronic kidney failure	1.66e-05	8.32e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—POMC—chronic kidney failure	1.66e-05	8.28e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—SREBF1—chronic kidney failure	1.65e-05	8.26e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—LPL—chronic kidney failure	1.65e-05	8.23e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NGF—chronic kidney failure	1.64e-05	8.19e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NGF—chronic kidney failure	1.63e-05	8.15e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—DDC—chronic kidney failure	1.63e-05	8.13e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—LPL—chronic kidney failure	1.63e-05	8.13e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—CCL2—chronic kidney failure	1.62e-05	8.1e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—AVP—chronic kidney failure	1.62e-05	8.09e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—HMGCR—chronic kidney failure	1.61e-05	8.03e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CAT—chronic kidney failure	1.61e-05	8.03e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—SCARB1—chronic kidney failure	1.6e-05	8.02e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCR5—chronic kidney failure	1.59e-05	7.96e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS1—chronic kidney failure	1.59e-05	7.94e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—AVP—chronic kidney failure	1.59e-05	7.92e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCR5—chronic kidney failure	1.59e-05	7.92e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	1.58e-05	7.9e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PRKD1—chronic kidney failure	1.58e-05	7.9e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	1.58e-05	7.9e-05	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.58e-05	7.88e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—FASN—chronic kidney failure	1.57e-05	7.86e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CYP1A1—chronic kidney failure	1.57e-05	7.85e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ABCB1—chronic kidney failure	1.56e-05	7.81e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NGF—chronic kidney failure	1.56e-05	7.8e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—SREBF1—chronic kidney failure	1.56e-05	7.78e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Hemostasis—KRAS—chronic kidney failure	1.54e-05	7.71e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—EDN1—chronic kidney failure	1.54e-05	7.7e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL5—chronic kidney failure	1.53e-05	7.64e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCR5—chronic kidney failure	1.52e-05	7.58e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—HMGCR—chronic kidney failure	1.51e-05	7.57e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—EDN1—chronic kidney failure	1.51e-05	7.54e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL5—chronic kidney failure	1.5e-05	7.48e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—LPL—chronic kidney failure	1.49e-05	7.47e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—LPL—chronic kidney failure	1.49e-05	7.45e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—POMC—chronic kidney failure	1.48e-05	7.42e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—FASN—chronic kidney failure	1.48e-05	7.41e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SREBF2—chronic kidney failure	1.48e-05	7.39e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—AVP—chronic kidney failure	1.47e-05	7.36e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MTHFR—chronic kidney failure	1.46e-05	7.32e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—LPL—chronic kidney failure	1.46e-05	7.31e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CYP3A4—chronic kidney failure	1.46e-05	7.28e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CYP1A1—chronic kidney failure	1.44e-05	7.19e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PPARA—chronic kidney failure	1.44e-05	7.18e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ABCA1—chronic kidney failure	1.43e-05	7.16e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—GCKR—chronic kidney failure	1.43e-05	7.14e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCC3—chronic kidney failure	1.43e-05	7.14e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NGF—chronic kidney failure	1.42e-05	7.07e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—EDN1—chronic kidney failure	1.4e-05	7e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LPIN1—chronic kidney failure	1.4e-05	6.99e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL5—chronic kidney failure	1.39e-05	6.95e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NGF—chronic kidney failure	1.39e-05	6.93e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCR5—chronic kidney failure	1.38e-05	6.88e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	1.37e-05	6.86e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LRP2—chronic kidney failure	1.37e-05	6.85e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	1.37e-05	6.85e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—F2—chronic kidney failure	1.37e-05	6.83e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—F2—chronic kidney failure	1.36e-05	6.8e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—LPL—chronic kidney failure	1.36e-05	6.79e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ALB—chronic kidney failure	1.35e-05	6.76e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ABCA1—chronic kidney failure	1.35e-05	6.75e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCR5—chronic kidney failure	1.35e-05	6.74e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MTHFR—chronic kidney failure	1.34e-05	6.7e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PPARA—chronic kidney failure	1.32e-05	6.58e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—F2—chronic kidney failure	1.3e-05	6.51e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—NOS3—chronic kidney failure	1.29e-05	6.47e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IRS1—chronic kidney failure	1.29e-05	6.46e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NGF—chronic kidney failure	1.29e-05	6.43e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IRS1—chronic kidney failure	1.29e-05	6.43e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCR5—chronic kidney failure	1.25e-05	6.26e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—POMC—chronic kidney failure	1.25e-05	6.22e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—POMC—chronic kidney failure	1.24e-05	6.19e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IRS1—chronic kidney failure	1.23e-05	6.16e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—CCL2—chronic kidney failure	1.22e-05	6.09e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CAT—chronic kidney failure	1.21e-05	6.06e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—CCL2—chronic kidney failure	1.21e-05	6.06e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IGF1—chronic kidney failure	1.2e-05	5.99e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IGF1—chronic kidney failure	1.19e-05	5.96e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—POMC—chronic kidney failure	1.19e-05	5.93e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—PTGS2—chronic kidney failure	1.18e-05	5.92e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—F2—chronic kidney failure	1.18e-05	5.9e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—POMC—chronic kidney failure	1.17e-05	5.85e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CPT1A—chronic kidney failure	1.16e-05	5.82e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—CCL2—chronic kidney failure	1.16e-05	5.8e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—F2—chronic kidney failure	1.16e-05	5.78e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CAT—chronic kidney failure	1.14e-05	5.71e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IGF1—chronic kidney failure	1.14e-05	5.7e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—SERPINE1—chronic kidney failure	1.14e-05	5.69e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LIPC—chronic kidney failure	1.13e-05	5.67e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	1.13e-05	5.67e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—SERPINE1—chronic kidney failure	1.13e-05	5.66e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—KRAS—chronic kidney failure	1.13e-05	5.63e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—LPL—chronic kidney failure	1.12e-05	5.62e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—KRAS—chronic kidney failure	1.12e-05	5.6e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IRS1—chronic kidney failure	1.12e-05	5.58e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ABCB1—chronic kidney failure	1.11e-05	5.56e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IRS1—chronic kidney failure	1.09e-05	5.47e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NOS3—chronic kidney failure	1.09e-05	5.43e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CYP1A1—chronic kidney failure	1.09e-05	5.43e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—SERPINE1—chronic kidney failure	1.08e-05	5.41e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NOS3—chronic kidney failure	1.08e-05	5.4e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—POMC—chronic kidney failure	1.08e-05	5.38e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—F2—chronic kidney failure	1.07e-05	5.37e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—POMC—chronic kidney failure	1.07e-05	5.36e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—KRAS—chronic kidney failure	1.07e-05	5.36e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ALB—chronic kidney failure	1.07e-05	5.33e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—LPL—chronic kidney failure	1.06e-05	5.29e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—POMC—chronic kidney failure	1.05e-05	5.27e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—CCL2—chronic kidney failure	1.05e-05	5.26e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SCARB1—chronic kidney failure	1.05e-05	5.24e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS1—chronic kidney failure	1.04e-05	5.19e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IGF1—chronic kidney failure	1.03e-05	5.17e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NOS3—chronic kidney failure	1.03e-05	5.17e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—CCL2—chronic kidney failure	1.03e-05	5.15e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	1.02e-05	5.11e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—RELA—chronic kidney failure	1.02e-05	5.11e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—NOS3—chronic kidney failure	1.02e-05	5.1e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SREBF1—chronic kidney failure	1.02e-05	5.09e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—RELA—chronic kidney failure	1.02e-05	5.08e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IRS1—chronic kidney failure	1.02e-05	5.08e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IGF1—chronic kidney failure	1.01e-05	5.06e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MTHFR—chronic kidney failure	1.01e-05	5.06e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PPARA—chronic kidney failure	9.93e-06	4.96e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—HMGCR—chronic kidney failure	9.9e-06	4.95e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—SERPINE1—chronic kidney failure	9.83e-06	4.91e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—POMC—chronic kidney failure	9.79e-06	4.89e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ALB—chronic kidney failure	9.78e-06	4.89e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—RELA—chronic kidney failure	9.73e-06	4.87e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—KRAS—chronic kidney failure	9.73e-06	4.86e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—FASN—chronic kidney failure	9.69e-06	4.84e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—SERPINE1—chronic kidney failure	9.62e-06	4.81e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—CCL2—chronic kidney failure	9.58e-06	4.79e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MTHFR—chronic kidney failure	9.54e-06	4.77e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—KRAS—chronic kidney failure	9.52e-06	4.76e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IGF1—chronic kidney failure	9.41e-06	4.71e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NOS3—chronic kidney failure	9.38e-06	4.69e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PPARA—chronic kidney failure	9.36e-06	4.68e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—NOS3—chronic kidney failure	9.35e-06	4.68e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PTGS2—chronic kidney failure	9.34e-06	4.67e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NOS3—chronic kidney failure	9.19e-06	4.59e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—IL6—chronic kidney failure	9.16e-06	4.58e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—IL6—chronic kidney failure	9.11e-06	4.56e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—SERPINE1—chronic kidney failure	8.94e-06	4.47e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—KRAS—chronic kidney failure	8.85e-06	4.42e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—RELA—chronic kidney failure	8.83e-06	4.41e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCA1—chronic kidney failure	8.83e-06	4.41e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—IL6—chronic kidney failure	8.72e-06	4.36e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—RELA—chronic kidney failure	8.65e-06	4.32e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NFKB1—chronic kidney failure	8.62e-06	4.31e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NFKB1—chronic kidney failure	8.58e-06	4.29e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PTGS2—chronic kidney failure	8.56e-06	4.28e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NOS3—chronic kidney failure	8.54e-06	4.27e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NFKB1—chronic kidney failure	8.21e-06	4.1e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—POMC—chronic kidney failure	8.09e-06	4.05e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—RELA—chronic kidney failure	8.03e-06	4.02e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—IL6—chronic kidney failure	7.91e-06	3.96e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—VEGFA—chronic kidney failure	7.82e-06	3.91e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—VEGFA—chronic kidney failure	7.78e-06	3.89e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—IL6—chronic kidney failure	7.75e-06	3.87e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—POMC—chronic kidney failure	7.63e-06	3.81e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CAT—chronic kidney failure	7.47e-06	3.73e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—VEGFA—chronic kidney failure	7.45e-06	3.72e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NFKB1—chronic kidney failure	7.45e-06	3.72e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ALB—chronic kidney failure	7.38e-06	3.69e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NFKB1—chronic kidney failure	7.29e-06	3.65e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ABCB1—chronic kidney failure	7.27e-06	3.63e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—IL6—chronic kidney failure	7.2e-06	3.6e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TGFB1—chronic kidney failure	7.18e-06	3.59e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TGFB1—chronic kidney failure	7.14e-06	3.57e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NOS3—chronic kidney failure	7.06e-06	3.53e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ALB—chronic kidney failure	6.95e-06	3.48e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—LPL—chronic kidney failure	6.93e-06	3.46e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TGFB1—chronic kidney failure	6.84e-06	3.42e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NFKB1—chronic kidney failure	6.78e-06	3.39e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—VEGFA—chronic kidney failure	6.76e-06	3.38e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	6.69e-06	3.34e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NOS3—chronic kidney failure	6.65e-06	3.32e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—KRAS—chronic kidney failure	6.65e-06	3.32e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—VEGFA—chronic kidney failure	6.62e-06	3.31e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—KRAS—chronic kidney failure	6.62e-06	3.31e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PTGS2—chronic kidney failure	6.46e-06	3.23e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—KRAS—chronic kidney failure	6.33e-06	3.17e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MTHFR—chronic kidney failure	6.24e-06	3.12e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TGFB1—chronic kidney failure	6.2e-06	3.1e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—VEGFA—chronic kidney failure	6.15e-06	3.07e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PPARA—chronic kidney failure	6.12e-06	3.06e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PTGS2—chronic kidney failure	6.08e-06	3.04e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TGFB1—chronic kidney failure	6.07e-06	3.04e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—KRAS—chronic kidney failure	5.75e-06	2.87e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TGFB1—chronic kidney failure	5.64e-06	2.82e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—KRAS—chronic kidney failure	5.63e-06	2.81e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—IL6—chronic kidney failure	5.41e-06	2.7e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—IL6—chronic kidney failure	5.38e-06	2.69e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—KRAS—chronic kidney failure	5.23e-06	2.61e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—IL6—chronic kidney failure	5.15e-06	2.58e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—POMC—chronic kidney failure	4.99e-06	2.49e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—IL6—chronic kidney failure	4.67e-06	2.34e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—IL6—chronic kidney failure	4.58e-06	2.29e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ALB—chronic kidney failure	4.55e-06	2.27e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NOS3—chronic kidney failure	4.35e-06	2.17e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—IL6—chronic kidney failure	4.25e-06	2.13e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PTGS2—chronic kidney failure	3.98e-06	1.99e-05	CbGpPWpGaD
